The Estimation of the Imposed Economic Burden Due to Inadequate Medical Care in Patients Suffering from Type 2 Diabetes in Tehran

Document Type : Original Article

Authors

1 PhD in Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences (Corresponding Author)

2 PhD in Pharmacoeconomics and Pharmaceutical Administration, Associate Professor at Faculty of Pharmacy, Tehran University of Medical Sciences

Abstract

Background: The purpose of this study is to evaluate the effect of inadequate (medical) care on the final outcome (micro and macrovascular effects) and imposed costs in Iranian patients suffering from type 2 diabetes.
Method: The study is a cross-sectional one conducted among patients suffering from type 2 diabetes in two main diabetes clinics (a private and a public one) in Tehran province. Using the UKPDS model and 5-year clinical data collected from main diabetes centers in Tehran provinces (400 patients), outcomes for the current care were predicted, and then these values were predicted for 20 years, assuming that the three main factors of LDL, HbA1C, and systolic blood pressure at standard level have been controlled. The obtained results compared with the current care outcomes are considered economic and health burden imposed on these patients due to inappropriate, inadequate or poor care.
Findings: Comparison of the 20-year results of the two scenarios shows that compared to the current treatment pattern, patients’ life expectancy can increase by 4.3 years as a result of modifying treatment patterns and controlling main variables.
Findings show that treatment costs for controlling the mentioned factors increased by 63,889,695 rials and total costs increased by 104,852,150 rials in optimal care.
Conclusion: The results of the model show that regarding type 2 diabetes population in the country (about 5 million people), about 30 million years and an average of over 1.5 million years annually are lost. Given that the cost of living in full care is less than 3 times the country’s per capita income, providing full care for diabetics is a highly cost-effective plan.
 

Keywords

Files

History

  • Receive Date: 11 August 2020
  • Accept Date: 11 August 2020

Share

How to cite

Statistics